Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

DGAP-News: Nemetschek Group appoints new Chief Division Officer for Operate & Manage and Digital Twin: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24062/Nemetschek_AG_Logo.svg.png
DGAP-News: Nemetschek Group appoints new Chief Division Officer for Operate & Manage and Digital Twin
DGAP-News: Nemetschek Group appoints new Chief Division Officer for Operate & Manage and Digital Twin
DGAP-News: MorphoSys appoints Tim Demuth as new Chief Research and Development Officer, following the retirement of Malte Peters: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
DGAP-News: MorphoSys appoints Tim Demuth as new Chief Research and Development Officer, following the retirement of Malte Peters
DGAP-News: MorphoSys appoints Tim Demuth as new Chief Research and Development Officer, following the retirement of Malte Peters
DGAP-News: Evotec expands clinical and commercial drug substance manufacturing with acquisition of Central Glass Germany: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: Evotec expands clinical and commercial drug substance manufacturing with acquisition of Central Glass Germany
DGAP-News: Evotec expands clinical and commercial drug substance manufacturing with acquisition of Central Glass Germany
DGAP-News: Nagarro SE posts 65.0% YoY revenue growth in Q2: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png
DGAP-News: Nagarro SE posts 65.0% YoY revenue growth in Q2
DGAP-News: Nagarro SE posts 65.0% YoY revenue growth in Q2
DGAP-News: freenet raises guidance for 2022 on the back of a strong first half-year: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24058/375px-Freenet_AG_Logo.svg.png
DGAP-News: freenet raises guidance for 2022 on the back of a strong first half-year
DGAP-News: freenet raises guidance for 2022 on the back of a strong first half-year
DGAP-News: CANCOM: Group revenue in the second quarter at the prior year's level. Noticeable improvements visible since June. : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24051/375px-PLAN._BUILT._PERFORM..png
DGAP-News: CANCOM: Group revenue in the second quarter at the prior year's level. Noticeable improvements visible since June.
DGAP-News: CANCOM: Group revenue in the second quarter at the prior year's level. Noticeable improvements visible since June.
DGAP-News: Bechtle Remains on Track to Success: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24050/225px-Bechtle_AG_20xx_logo.svg.png
DGAP-News: Bechtle Remains on Track to Success
DGAP-News: Bechtle Remains on Track to Success
DGAP-News: Evotec SE reports results for the first half-year 2022 and provides corporate updates: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: Evotec SE reports results for the first half-year 2022 and provides corporate updates
DGAP-News: Evotec SE reports results for the first half-year 2022 and provides corporate updates
DGAP-News: VARTA AG: VARTA AG is confident about the second half of the year, despite the global challenges: https://upload.wikimedia.org/wikipedia/commons/thumb/1/13/Varta-Logo.svg/1000px-Varta-Logo.svg.png
DGAP-News: VARTA AG: VARTA AG is confident about the second half of the year, despite the global challenges
DGAP-News: VARTA AG: VARTA AG is confident about the second half of the year, despite the global challenges
DGAP-News: Just – Evotec Biologics and Alpine Immune Sciences expand partnership for commercial process development of ALPN-303: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: Just – Evotec Biologics and Alpine Immune Sciences expand partnership for commercial process development of ALPN-303
DGAP-News: Just – Evotec Biologics and Alpine Immune Sciences expand partnership for commercial process development of ALPN-303
DGAP-News: Evotec SE reports first half-year 2022 results on 11 August 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: Evotec SE reports first half-year 2022 results on 11 August 2022
DGAP-News: Evotec SE reports first half-year 2022 results on 11 August 2022
DGAP-News: 1&1 with successful first half, forecast for 2022 confirmed: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24057/Drillisch_AG_Logo.svg.png
DGAP-News: 1&1 with successful first half, forecast for 2022 confirmed
DGAP-News: 1&1 with successful first half, forecast for 2022 confirmed
DGAP-News: United Internet with successful first half-year 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24075/330px-UnitedInternet_logo.svg.png
DGAP-News: United Internet with successful first half-year 2022
DGAP-News: United Internet with successful first half-year 2022
DGAP-News: MorphoSys AG Reports Second Quarter and First Half 2022 Financial Results: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
DGAP-News: MorphoSys AG Reports Second Quarter and First Half 2022 Financial Results
DGAP-News: MorphoSys AG Reports Second Quarter and First Half 2022 Financial Results
DGAP-Adhoc: VARTA AG: Preliminary results for the first half of 2022 and adjustment of outlook for the current financial year: https://upload.wikimedia.org/wikipedia/commons/thumb/1/13/Varta-Logo.svg/1000px-Varta-Logo.svg.png
DGAP-Adhoc: VARTA AG: Preliminary results for the first half of 2022 and adjustment of outlook for the current financial year
DGAP-Adhoc: VARTA AG: Preliminary results for the first half of 2022 and adjustment of outlook for the current financial year
DGAP-News: VARTA AG: VARTA AG expands Executive Board and extends Contract of Chief Financial Officer Armin Hessenberger: https://upload.wikimedia.org/wikipedia/commons/thumb/1/13/Varta-Logo.svg/1000px-Varta-Logo.svg.png
DGAP-News: VARTA AG: VARTA AG expands Executive Board and extends Contract of Chief Financial Officer Armin Hessenberger
DGAP-News: VARTA AG: VARTA AG expands Executive Board and extends Contract of Chief Financial Officer Armin Hessenberger
DGAP-News: Siltronic AG posts strong sales growth and high earnings in second quarter  of 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24068/Siltronic_Logo.svg.png
DGAP-News: Siltronic AG posts strong sales growth and high earnings in second quarter of 2022
DGAP-News: Siltronic AG posts strong sales growth and high earnings in second quarter of 2022
DGAP-News: MorphoSys AG: Invitation to MorphoSys’ Second Quarter and First Half Year 2022 Results Conference Call on August 4 , 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
DGAP-News: MorphoSys AG: Invitation to MorphoSys’ Second Quarter and First Half Year 2022 Results Conference Call on August 4 , 2022
DGAP-News: MorphoSys AG: Invitation to MorphoSys’ Second Quarter and First Half Year 2022 Results Conference Call on August 4 , 2022
DGAP-News: Nemetschek Group continues its strong double-digit growth in revenue and profitability in Q2 2022 and confirms its outlook for 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24062/Nemetschek_AG_Logo.svg.png
DGAP-News: Nemetschek Group continues its strong double-digit growth in revenue and profitability in Q2 2022 and confirms its outlook for 2022
DGAP-News: Nemetschek Group continues its strong double-digit growth in revenue and profitability in Q2 2022 and confirms its outlook for 2022
DGAP-News: Telefónica Deutschland Holding AG: Expanding FY22 OIBDA outlook on sustained commercial traction & financial performance: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24073/Telefonica_Logo.svg.png
DGAP-News: Telefónica Deutschland Holding AG: Expanding FY22 OIBDA outlook on sustained commercial traction & financial performance
DGAP-News: Telefónica Deutschland Holding AG: Expanding FY22 OIBDA outlook on sustained commercial traction & financial performance
DGAP-Adhoc: QIAGEN N.V.: QIAGEN increases full-year 2022 outlook: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24065/Qiagen_Logo.svg.png
DGAP-Adhoc: QIAGEN N.V.: QIAGEN increases full-year 2022 outlook
DGAP-Adhoc: QIAGEN N.V.: QIAGEN increases full-year 2022 outlook
DGAP-Adhoc: Siltronic AG adjusts dividend policy and plans a dividend of EUR 3.00 for fiscal 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24068/Siltronic_Logo.svg.png
DGAP-Adhoc: Siltronic AG adjusts dividend policy and plans a dividend of EUR 3.00 for fiscal 2022
DGAP-Adhoc: Siltronic AG adjusts dividend policy and plans a dividend of EUR 3.00 for fiscal 2022
DGAP-News: MorphoSys Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022 : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
DGAP-News: MorphoSys Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022
DGAP-News: MorphoSys Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022
DGAP-Adhoc: Ad hoc: MorphoSys AG Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
DGAP-Adhoc: Ad hoc: MorphoSys AG Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022
DGAP-Adhoc: Ad hoc: MorphoSys AG Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022
DGAP-Adhoc: Bechtle AG: Again strong EBT growth in Q2: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24050/225px-Bechtle_AG_20xx_logo.svg.png
DGAP-Adhoc: Bechtle AG: Again strong EBT growth in Q2
DGAP-Adhoc: Bechtle AG: Again strong EBT growth in Q2